Package 53746-254-02

{"route": ["ORAL"], "spl_id": "8625e9c6-6542-43d2-a657-34161884a7d0", "openfda": {"upc": ["0353746254016", "0353746253019"], "unii": ["BK76465IHM"], "rxcui": ["198191", "198193"], "spl_set_id": ["b38a3332-5c54-453f-aeb7-070f830955c2"], "manufacturer_name": ["Amneal Pharmaceuticals of New York LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (53746-254-01)", "package_ndc": "53746-254-01", "marketing_start_date": "20091216"}, {"sample": false, "description": "250 TABLET in 1 BOTTLE (53746-254-02)", "package_ndc": "53746-254-02", "marketing_start_date": "20091216"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (53746-254-30)", "package_ndc": "53746-254-30", "marketing_start_date": "20091216"}], "brand_name": "Ranitidine", "product_id": "53746-254_8625e9c6-6542-43d2-a657-34161884a7d0", "dosage_form": "TABLET", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "53746-254", "generic_name": "Ranitidine", "labeler_name": "Amneal Pharmaceuticals of New York LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ranitidine", "active_ingredients": [{"name": "RANITIDINE HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA077824", "marketing_category": "ANDA", "marketing_start_date": "20091216", "listing_expiration_date": "20261231"}